- Supported exchanges /
- TWO /
- 4726.TWO
Mycenax Biotech (4726 TWO) stock market data APIs
Mycenax Biotech Inc. develops and manufactures biopharmaceutical products from mammalian and microbial cell lines in Taiwan, Europe, Asia, and the United States. The company develops monoclonal antibodies, bi-specific antibodies, fc-fusion proteins, recombinant proteins, peptides, protein conjugates (non-toxin), antibody-cell conjugates, enzymes, antigen-binding fragments (Fab), and single-chain variable fragments (ScFv), as well as plasmids and DNA vaccines. It also provides process development solutions, including development of production cell lines, upstream and downstream process development, process scale-up, formulation development, and analytical methods; in-house analytical services; GMP manufacturing services, such as drug substance and products manufacturing, and cell banking; and manufacturing technologies. The company was founded in 2001 and is headquartered in Zhubei, Taiwan.
Mycenax Biotech Financial Data Overview
| 50.4 | |
| 50 | |
| - | |
| 51.2 | |
| 50 | |
| 34.9-65.2 | |
| 10 402 M | |
| 206 M | |
| 577 M | |
| -0.74 | |
| 1.061 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
Mycenax Biotech Fundamental Data is available in our Financial Data APIs
- Net Revenue 577 M
- EBITDA -243 624 992
- Earnings Per Share -2.48
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get Mycenax Biotech Earnings via APIs
- Latest Release 2024-03-13
- EPS/Forecast NaN
Get Mycenax Biotech End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also:
